A. KARAOĞLU Et Al. , "Efficacy and tolerability of biweekly gemcitabine plus cisplatin GEMCIS or gemcitabine plus paclitaxel GEMPAC as neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder," ASCO Annual Meeting , Chicago, United States Of America, 2012
KARAOĞLU, A. Et Al. 2012. Efficacy and tolerability of biweekly gemcitabine plus cisplatin GEMCIS or gemcitabine plus paclitaxel GEMPAC as neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder. ASCO Annual Meeting , (Chicago, United States Of America).
KARAOĞLU, A., Nieh, P., Canter, D., Master, V. A., Carthon, B., Harris, W., ... Shelton, J.(2012). Efficacy and tolerability of biweekly gemcitabine plus cisplatin GEMCIS or gemcitabine plus paclitaxel GEMPAC as neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder . ASCO Annual Meeting, Chicago, United States Of America
KARAOĞLU, AZİZ Et Al. "Efficacy and tolerability of biweekly gemcitabine plus cisplatin GEMCIS or gemcitabine plus paclitaxel GEMPAC as neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder," ASCO Annual Meeting, Chicago, United States Of America, 2012
KARAOĞLU, AZİZ Et Al. "Efficacy and tolerability of biweekly gemcitabine plus cisplatin GEMCIS or gemcitabine plus paclitaxel GEMPAC as neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder." ASCO Annual Meeting , Chicago, United States Of America, 2012
KARAOĞLU, A. Et Al. (2012) . "Efficacy and tolerability of biweekly gemcitabine plus cisplatin GEMCIS or gemcitabine plus paclitaxel GEMPAC as neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder." ASCO Annual Meeting , Chicago, United States Of America.
@conferencepaper{conferencepaper, author={AZİZ KARAOĞLU Et Al. }, title={Efficacy and tolerability of biweekly gemcitabine plus cisplatin GEMCIS or gemcitabine plus paclitaxel GEMPAC as neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder}, congress name={ASCO Annual Meeting}, city={Chicago}, country={United States Of America}, year={2012}}